Une prise en charge de plus en personnalisée à tous les stades de la maladie : Cancer colorectalROUGIER, Philippe.Concours médical (Paris). 2011, Vol 133, Num 10, issn 0010-5309, p. 799Article

The treatment of undifferentiated neuroendocrine tumorsMITRY, Emmanuel; ROUGIER, Philippe.Critical reviews in oncology/hematology. 2001, Vol 37, Num 1, pp 47-51, issn 1040-8428Article

Cancers colorectaux Quels progrès attendus a court terme ? : Cancer colorectal = Colorectal cancer: which progress in next years? : Colorectal cancerBACHET, Jean-Baptiste; ROUGIER, Philippe.La Revue du praticien (Paris). 2010, Vol 60, Num 8, issn 0035-2640, 1041, 1111-1115 [6 p.]Article

Adénocarcinomes de l'estomac et de la jonction œsogastrique: Approches néoadjuvantes et adjuvantes: le point en 2011 : LE CANCER DE L'ESTOMAC = Gastroesophageal adenocarcinomas: Neoadjuvant and adjuvant treatments in 2011: A reviewSAMALIN, Emmanuelle; YCHOU, Marc; ROUGIER, Philippe et al.Cancéro digest. 2011, Vol 3, Num 2, pp 108-115, issn 1953-5171, 8 p.Article

Prise en charge globale des patients atteints de cancers colo-rectaux : Cancers colo-rectaux = Colorectal cancer management : Colorectal cancersROUGIER, Philippe; CLAVERO-FABRI, Marie-Christine; MITRY, Emmanuel et al.La Revue du praticien (Paris). 2004, Vol 54, Num 2, pp 177-183, issn 0035-2640, 7 p.Article

Digestive neuroendocrine tumors (DNET): The era of targeted therapiesBOUSSAHA, Tarek; ROUGIER, Philippe; TAIEB, Julien et al.Clinics and research in hepatology and gastroenterology (Print). 2013, Vol 37, Num 2, pp 134-141, issn 2210-7401, 8 p.Article

Quelle prévention le médecin généraliste peut-il exercer ? Informer et dépister : Cancer colorectalCLAVERO, José; CLAVERO-FABRI, Marie-Christine; ROUGIER, Philippe et al.Concours médical (Paris). 2011, Vol 133, Num 10, pp 786-788, issn 0010-5309, 3 p.Article

TUMEURS DU CÔLON ET DU RECTUM = Colon and rectal tumourBACHET, Jean-Baptiste; LESUR, Gilles; ROUGIER, Philippe et al.La Revue du praticien (Paris). 2009, Vol 59, Num 3, pp 383-391, issn 0035-2640, 9 p.Article

State of the art ― colorectal liver metastasesROUGIER, Philippe.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 3, pp 2-3, issn 1359-6349, 2 p.Conference Paper

La chimiothérapie à visée curative avant (neoadjuvante), ou aprés (adjuvante) la chirurgie des métastases hépatiques des cancers colo-rectaux : Avancées récentes dans le diagnostic et le traitement des métastases hépatiques des cancers colorectaux = Adjuvant and neoadjuvant chemotherapy for patients with resectable liver metastases from colorectal cancerROUGIER, Philippe; GUIMBAUD, Rosine; MITRY, Emmanuel et al.Bulletin de l'Académie nationale de médecine. 2003, Vol 187, Num 5, pp 881-892, issn 0001-4079, 12 p.Article

Second-line treatment of patients with metastatic colorectal cancerROUGIER, Philippe; LEPERE, Celine.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S48-S54, SUP9Conference Paper

Qu'apporte la réponse tumorale dans le cancer colorectal ? = What is the contribution of tumor response in colorectal cancer?BACHET, Jean-Baptiste; PAOLETTI, Xavier; FOURNIER, Laure et al.Bulletin du cancer. 2013, Vol 100, Num 7-8, pp 743-755, issn 0007-4551, 13 p.Article

Irinotecan as palliative chemotherapy for metastatic colorectal cancer : evolving tactics following initial treatmentMITRY, Emmanuel; LIEVRE, Astrid; BACHET, Jean-Baptiste et al.International journal of colorectal disease (Print). 2009, Vol 24, Num 6, pp 605-612, issn 0179-1958, 8 p.Article

Metastatic colorectal cancer : First- and second-line treatment in 2005ROUGIER, Philippe; LEPERE, Céline.Seminars in oncology. 2005, Vol 32, Num 6, pp S15-S20, issn 0093-7754, SUP8Conference Paper

Calculating yttrium-90 activity with clinical considerationsKENNEDY, Andrew S.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 3, pp 59-61, issn 1359-6349, 3 p.Conference Paper

Liver resection post-selective internal radiation therapy ― an overviewBERRY, David P.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 3, pp 36-38, issn 1359-6349, 3 p.Conference Paper

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II TrialYAO, James C; LOMBARD-BOHAS, Catherine; VAN CUTSEM, Eric et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 69-76, issn 0732-183X, 8 p.Article

Risk factors for chemotherapy-associated liver injuries : A multivariate analysis of a group of 146 patients with colorectal metastasesBROUQUET, Antoine; BENOIST, Stéphane; JULIE, Catherine et al.Surgery. 2009, Vol 145, Num 4, pp 362-371, issn 0039-6060, 10 p.Conference Paper

Cutaneous Perianal Recurrence on the Site of Lone Star Retractor™ after J-pouch Coloanal Anastomosis for Rectal Cancer : Report of Two CasesTRANCHART, Hadrien; BENOIST, Stéphane; PENNA, Christophe et al.Diseases of the colon & rectum. 2008, Vol 51, Num 12, pp 1850-1852, issn 0012-3706, 3 p.Article

Hepatocellular carcinoma (HCC) : An updateROUGIER, Philippe; MITRY, Emmanuel; BARBARE, Jean-Claude et al.Seminars in oncology. 2007, Vol 34, Num 2, issn 0093-7754, S12-S20, SUP1Conference Paper

Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases : FFCE ACHBTH AURC 9002 trialPORTIER, Guillaume; ELIAS, Dominique; BUGAT, Roland et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 4976-4982, issn 0732-183X, 7 p.Article

Chimiothérapie des adénocarcinomes du pancréas non résécables par 5-fluorouracile, acide folinique et cisplatine (LV5FU2-P) = 5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancerTAÏEB, Julien; LECOMTE, Thierry; EZENFIS, Joël et al.Gastroentérologie clinique et biologique. 2002, Vol 26, Num 6-7, pp 605-609, issn 0399-8320Article

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyVAN CUTSEM, Eric; TWELVES, Chris; MCKENDRICK, Joe et al.Journal of clinical oncology. 2001, Vol 19, Num 21, pp 4097-4106, issn 0732-183XArticle

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumorsDUCREUX, Michel; RUSZNIEWSKI, Philippe; GENESTIN, Elisabeth et al.The American journal of gastroenterology. 2000, Vol 95, Num 11, pp 3276-3281, issn 0002-9270Article

Colorectal cancer chemotherapy: IrinotecanROUGIER, Philippe; MITRY, Emmanuel.Seminars in oncology. 2000, Vol 27, Num 5, pp 138-143, issn 0093-7754, SUP10Conference Paper